Author/Creator: Lin, Guifeng - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Lin, Guifeng

1. Discovery of 1, 8-disubstituted-[1, 2, 3]triazolo[4, 5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors. Issue 18 (15th September 2019)

Authors:: Qiao, Jingxin; Lin, Guifeng; Xia, Anjie; Xiang, Zhiyu; Chen, Pei; Zhang, Guo; Li, Linli; Yang, Shengyong
Journal:: Bioorganic & medicinal chemistry letters
Issue:: Volume 29:Issue 18(2019)
Page Start:: 2595
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. (8th March 2021)

Authors:: Guo, Yinping; Mao, Xin; Xiong, Liang; Xia, Anjie; You, Jing; Lin, Guifeng; Wu, Chengyong; Huang, Luyi; Wang, Yiwei; Yang, Shengyong
Journal:: Angewandte Chemie
Issue:: Volume 133:Number 16(2021)
Page Start:: 8842
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Discovery of 6, 7-dihydro-5H-pyrrolo[3, 4-d] pyrimidine derivatives as a new class of ATR inhibitors. (1st May 2022)

Authors:: Chen, Pei; Bin, Huachao; Jiao, Yan; Lin, Guifeng; Zhang, Yun; Xia, Anjie; Pan, Zhilin; Qiao, Jingxin; Guo, Yinping; Liu, Jingming; Zhou, Yangli; Li, Linli
Journal:: Bioorganic & medicinal chemistry letters
Issue:: Volume 63(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. Issue 16 (8th March 2021)

Authors:: Guo, Yinping; Mao, Xin; Xiong, Liang; Xia, Anjie; You, Jing; Lin, Guifeng; Wu, Chengyong; Huang, Luyi; Wang, Yiwei; Yang, Shengyong
Journal:: Angewandte Chemie international edition
Issue:: Volume 60:Issue 16(2021)
Page Start:: 8760
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Discovery of 1, 8-disubstituted-[1, 2, 3]triazolo[4, 5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors. Issue 18 (15th September 2019)

Authors:: Qiao, Jingxin; Lin, Guifeng; Xia, Anjie; Xiang, Zhiyu; Chen, Pei; Zhang, Guo; Li, Linli; Yang, Shengyong
Journal:: Bioorganic & medicinal chemistry letters
Issue:: Volume 29:Issue 18(2019)
Page Start:: 2595
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Discovery of 3, 4-dihydrobenzo[f][1, 4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucoma. (1st August 2021)

Authors:: Sun, Yumeng; Li, Yueshan; Miao, Zhuang; Yang, Ruicheng; Zhang, Yun; Wu, Ming; Lin, Guifeng; Li, Linli
Journal:: Bioorganic & medicinal chemistry letters
Issue:: Volume 45(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Discovery of 3, 6-disubstutited-imidazo[1, 2-a]pyridine derivatives as a new class of CLK1 inhibitors. (1st June 2021)

Authors:: Zhang, Yun; Xia, Anjie; Zhang, Shiyu; Lin, Guifeng; Liu, Jingming; Chen, Pei; Mu, Bo; Jiao, Yan; Xu, Wenwen; Chen, Mingxin; Li, Linli
Journal:: Bioorganic & medicinal chemistry letters
Issue:: Volume 41(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays. Issue 16 (22nd March 2019)

Authors:: Huang, Shenzhen; Wang, Xiang; Lin, Guifeng; Cheng, Jie; Chen, Xiuli; Sun, Weining; Xiang, Rong; Yu, Yamei; Li, Linli; Yang, Shengyong
Journal:: RSC advances
Issue:: Volume 9:Issue 16(2019)
Page Start:: 9323
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗